The Glasgow Prognostic Score (GPS) is an easily derived measure of underlying inflammatory processes. In this series of 101 patients with newly diagnosed advanced non-small cell lung carcinoma, it proved superior to the ECOG Performance Scale in predicting survival. After initial treatment, however, the prognostic value fell, but this may have been the result of fewer evaluable patients at the latter time points.